PACELLI PAOLA | Professor page

Caroni, F., Sammartano, V., Pacelli, P., Sicuranza, A., Malchiodi, M., Dragomir, A., et al. (2025). Minimal Residual Disease Significance in Multiple Myeloma Patients Treated with Anti-CD38 Monoclonal Antibodies. PHARMACEUTICALS, 18(2) [10.3390/ph18020159]. - view more
Sicuranza, A., Pacelli, P., Santoni, A., Abruzzese, E., Cattaneo, D., Iurlo, A., et al. (2025). Unravelling a clinical role of peripheral blood leukemia stem cells at diagnosis in chronic myeloid leukemia patients: Final results of prospective FLOWERS study. CANCER, 131(20) [10.1002/cncr.70122]. - view more
Sammartano, V., Sicuranza, A., Pacelli, P., Bestoso, E., Santoni, A., Brambilla, C.Z., et al. (2025). Prognostic value of CD47 overexpression measured by flow cytometry in acute myeloid leukemia. ANNALS OF HEMATOLOGY, 104(5), 2737-2743 [10.1007/s00277-025-06401-2]. - view more
Sicuranza, A., Breccia, M., Iuliano, F., Gugliotta, G., Castagnetti, F., Lunghi, M., et al. (2025). Therapeutic Vaccinations with p210 Peptides in Imatinib-Treated Chronic Myeloid Leukemia Patients: 10 Years Follow-Up of GIMEMA CML0206 and SI0207 Studies. VACCINES [10.3390/vaccines13040419]. - view more
Santoni, A., Malchiodi, M., Zappone, E., Cartocci, A., Sicuranza, A., Pacelli, P., et al. (2025). Low rate of infectious mortality omitting fluoroquinolone prophylaxis in high-risk hematological patients, a single centre experience. FRONTIERS IN MICROBIOLOGY, 16 [10.3389/fmicb.2025.1632055]. - view more